Analgesics in the United Arab Emirates

In the United Arab Emirates, analgesics can be categorised into two groups: products from international brands, and those from regional brands, which tend to be priced lower. By the end of the review period, the majority of analgesics brands were owned by international companies. However, local companies such as Julphar Gulf Pharmaceuticals with its brand Adol, and Neopharma with Neomol, have managed to attract consumers by offering more affordable options.

The analyst's Analgesics in United Arab Emirates report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage:
Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage:
Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Analgesics market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.